Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

The Role of Stress in Self-Control, Coping, and Emotion Regulation

This study has been completed.
Sponsor:
Collaborators:
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Rajita Sinha, Yale University
ClinicalTrials.gov Identifier:
NCT01554501
First received: March 1, 2012
Last updated: November 28, 2016
Last verified: November 2016
  Purpose
The purpose of this study is to examine the effects of stress on mental and physical health and behavior.

Condition
Stress

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: The Role of Stress in Self-Control, Coping and Emotion Regulation

Further study details as provided by Yale University:

Primary Outcome Measures:
  • Stress response and lifestyle behaviors [ Time Frame: Baseline ]
    Study explores differences in measures of stress as they relate to self-control, coping, emotion regulation and lifestyle and health outcomes.


Secondary Outcome Measures:
  • Biological stress responses [ Time Frame: Baseline ]

Biospecimen Retention:   Samples With DNA
Blood taken for understanding genetic factors.

Enrollment: 855
Study Start Date: November 2007
Study Completion Date: December 2015
Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
Community sample

  Eligibility

Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Community sample
Criteria

Inclusion Criteria:

  • ages 18-50
  • able to read and write

Exclusion Criteria:

  • Any psychotic disorder or current psychiatric symptoms requiring specific attention, including active symptoms of psychosis or suicidal/homicidal ideation
  • Pregnant women
  • Inability to give informed consent
  • Traumatic brain injury or loss of consciousness
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01554501

Locations
United States, Connecticut
Yale Stress Center
New Haven, Connecticut, United States, 06519
Sponsors and Collaborators
Yale University
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Rajita Sinha, PhD Yale University
  More Information

Responsible Party: Rajita Sinha, Professor, Yale University
ClinicalTrials.gov Identifier: NCT01554501     History of Changes
Other Study ID Numbers: 0710003159
5PL1DA024859-05 ( US NIH Grant/Contract Award Number )
Study First Received: March 1, 2012
Last Updated: November 28, 2016

Keywords provided by Yale University:
stress
self-control
emotion regulation
health

ClinicalTrials.gov processed this record on April 28, 2017